Skip to main content

Table 3 Behavioural factors associated with anaemia during malaria in pregnancy using univariate

From: Socio-economic behavioural indicators of falciparum malaria parasitaemia and moderate to severe anaemia among pregnant women attending antenatal clinics in Lagos, Southwest Nigeria

Variable

Freq (%)

Anaemia

Mean (±sd) PCV

χ²

P-value

OR

95% CI

t-test

P-value

None/Mild

n (%)

Moderate/Severe

n (%)

Parasitaemia

22 (19.5)

3 (14.3)

19 (90.5)

26.8 (6.6)

2.33

0.13

3.11

0.85–11.36

−2.60

0.007

No parasitaemia

91 (80.5)

30 (32.6)

61 (66.3)

30.8 (6.0)

Education

 None

5 (4.4)

1 (20.0)

4 (80.0)

29.6 (5.5)

0.00

1.00

1.68

0.18–15.66

–

–

 Primary

13 (11.5)

1 (7.0)

12 (92.3)

28.9 (4.1)

2.22

0.14

5.65

0.70–45.33

0.26

0.40

 Secondary

51 (45.1)

18 (35.3)

33 (64.7)

29.9 (6.2)

1.67

0.20

0.58

0.26–1.32

−0.12

0.46

 Tertiary

44 (39.0)

13 (29.6)

31 (70.5)

30.6 (7.0)

0.004

0.95

0.97

0.42–2.23

−0.37

0.36

Pregnancy

 1st

32 (28.3)

11 (34.4)

21 (65.7)

29.6 (6.3)

0.58

0.45

0.71

0.30–1.71

−0.46

0.33

 > 1st

81 (71.7)

22 (27.1)

59 (72.8)

30.2 (6.3)

      

Trimester

 First

19 (16.8)

5 (15.1)

14 (17.5)

30.9 (7.2)

0.09

0.76

1.19

0.39, 3.61

–

–

 Second

54 (47.8)

15 (45.5)

39 (48.7)

29.5 (6.3)

0.10

0.75

1.14

0.51, 2.57

0.75

0.23

 Third

40 (35.4)

13 (39.4)

27 (33.8)

30.4 (5.9)

0.33

0.57

0.78

0.34, 1.81

0.26

0.60

Age (years)

 ≤ 20

4 (3.5)

1 (25.0)

3 (75.0)

30.3 (5.4)

0.00

1.00

1.25

0.12–12.44

–

–

 21–25

24 (21.2)

10 (41.7)

14 (58.4)

30.3 (7.4)

2.29

0.13

0.49

0.19–1.25

0.0

1.00

 26–30

36 (31.9)

6 (16.7)

30 (83.3)

29.1 (5.1)

4.02

0.04

2.70

1.00–7.29

0.42

0.35

 31–35

31 (27.4)

8 (25.8)

23 (74.2)

29.9 (7.1)

0.24

0.62

1.26

0.50–3.20

0.13

0.45

 > 35

18 (159)

8 (44.5)

10 (55.6)

31.9 (5.6)

2.40

0.12

0.45

0.16–1.26

−0.53

0.31

ITN

 Use

15 (13.3)

5 (33.3)

10 (66.7)

30.5 (6.5)

0.14

0.71

0.80

0.25–2.55

0.28

0.39

 Non-use

98 (86.7)

28 (28.6)

70 (71.4)

30.0 (6.3)

      

Anti-malarial

 Use

55 (48.7)

17 (30.9)

38 (69.1)

29.4 (6.2)

0.15

0.70

0.85

0.38–1.92

−1.01

0.16

 Non-use

58 (51.3)

16 (27.6)

42 (72.4)

30.6 (6.4)

      

IPTp

 Use

32 (28.3)

12 (37.5)

20 (62.5)

30.3 (6.7)

1.49

0.22

0.58

0.24–1.39

0.29

0.39

 Non-use

81 (71.7)

21 (25.9)

60 (74.1)

29.9 (6.1)

      

Herb

 Use

33 (29.2)

7 (21.2)

26 (78.8)

28.2 (5.2)

1.44

0.23

1.79

0.69–4.66

−2.23

0.01

 Non-use

80 (70.8)

26 (32.5)

54 (67.5)

30.8 (6.6)

     Â